Healthcare of Ontario Pension Plan (HOOPP) Trust Fund’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,840
Closed -$195K 1005
2023
Q2
$195K Buy
+4,840
New +$274K ﹤0.01% 978
2023
Q1
Sell
-8,324
Closed -$683K 1246
2022
Q4
$683K Buy
+8,324
New +$867K ﹤0.01% 954
2022
Q3
Sell
-24,676
Closed -$4.81M 1486
2022
Q2
$4.81M Buy
+24,676
New +$4.03M 0.02% 445
2021
Q3
Sell
-6,600
Closed -$2.57M 1679
2021
Q2
$2.57M Sell
6,600
-11,460
-63% -$4.09M 0.01% 912
2021
Q1
$6.48M Sell
18,060
-4,328
-19% -$1.91M 0.02% 419
2020
Q4
$11M Buy
22,388
+14,868
+198% +$6.86M 0.03% 337
2020
Q3
$2.44M Buy
+7,520
New +$2.56M 0.02% 338
2020
Q2
Sell
-3,014
Closed -$641K 829
2020
Q1
$641K Buy
+3,014
New +$957K 0.01% 454

Other funds holding ATRA

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's ATRA Position: Q3 2023 in Review

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund sold out of Atara Biotherapeutics (ATRA) in Q3 2023, closing a stake of 4,840 shares — an estimated $195K sold.

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in ATRA in Q1 2020 and held it in 8 quarters. The position peaked at $11M in Q4 2020. 109 funds tracked by Wall St. Rank hold ATRA as of Q3 2023.

  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund reported no remaining Atara Biotherapeutics position as of Q3 2023 after selling out during the quarter.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund sold 4,840 Atara Biotherapeutics shares in Q3 2023, an estimated $195K.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in Atara Biotherapeutics in Q1 2020 and held it in 8 quarters.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's Atara Biotherapeutics position peaked at $11M in Q4 2020.
  • 109 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2023.

Based on Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's 13F filing for Q3 2023, filed 13 Nov 2023.